Correlation Between Cyteir Therapeutics and Pardes Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Pardes Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Pardes Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Pardes Biosciences, you can compare the effects of market volatilities on Cyteir Therapeutics and Pardes Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Pardes Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Pardes Biosciences.

Diversification Opportunities for Cyteir Therapeutics and Pardes Biosciences

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cyteir and Pardes is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Pardes Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pardes Biosciences and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Pardes Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pardes Biosciences has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Pardes Biosciences go up and down completely randomly.

Pair Corralation between Cyteir Therapeutics and Pardes Biosciences

If you would invest  214.00  in Pardes Biosciences on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Pardes Biosciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cyteir Therapeutics  vs.  Pardes Biosciences

 Performance 
       Timeline  
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Pardes Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Cyteir Therapeutics and Pardes Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyteir Therapeutics and Pardes Biosciences

The main advantage of trading using opposite Cyteir Therapeutics and Pardes Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Pardes Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will offset losses from the drop in Pardes Biosciences' long position.
The idea behind Cyteir Therapeutics and Pardes Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk